Clinical Trial Update: Teriflunomide in HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicating recruitment for a Phase 1/2 study of teriflunomide in HTLV-1 associated myelopathy/tropical spastic paraparesis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Htlv-1 Associated Myelopathy Tropical Spastic Paraparesis

Drugs mentioned

• Teriflunomide (teriflunomide)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: HAM/TSP | Phase 1, Phase 2 | Status: RECRUITING